Mar. Drugs 2012, 10(12), 2782-2794; doi:10.3390/md10122782
Article

Antitumor Effect of a Polypeptide Fraction from Arca subcrenata in Vitro and in Vivo

1,†email, 2,* email, 1,†email, 1email and 1,2,* email
Received: 18 October 2012; in revised form: 20 November 2012 / Accepted: 29 November 2012 / Published: 11 December 2012
View Full-Text   |   Download PDF [1076 KB, uploaded 11 December 2012]
Abstract: Arca subcrenata Lischke is a marine traditional Chinese medicine. The study investigated the antitumor effects of P2, a polypeptide fraction from A. subcrenata, and its toxicity in vitro and in vivo. The results showed that P2 could inhibit the proliferation of seven tumor cell lines, especially in HeLa and HT-29 cell lines. The IC50 values were 11.43 μg/mL for HeLa and 13.00 μg/mL for HT-29 treated by P2 for 48 h. P2 had little cytotoxicity on normal liver cells (L-02). The maximum tolerated dose (MTD) of P2 on KM mice was 1000 mg/kg by i.p. or i.v. The tumor growth inhibitory ratios of P2 were 26.4%, 41.4% and 46.4% for H-22, and 34.0%, 45.8% and 60.1% for S-180 tumor-bearing mice. The results demonstrated that P2 might be a potential antitumor agent with high efficiency in dose-dependent and time-dependent manners and low toxicity.
Keywords: Arca subcrenata; polypeptide; antitumor; S-180; H-22
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Hu, X.; Song, L.; Huang, L.; Zheng, Q.; Yu, R. Antitumor Effect of a Polypeptide Fraction from Arca subcrenata in Vitro and in Vivo. Mar. Drugs 2012, 10, 2782-2794.

AMA Style

Hu X, Song L, Huang L, Zheng Q, Yu R. Antitumor Effect of a Polypeptide Fraction from Arca subcrenata in Vitro and in Vivo. Marine Drugs. 2012; 10(12):2782-2794.

Chicago/Turabian Style

Hu, Xianjing; Song, Liyan; Huang, Lijiao; Zheng, Qin; Yu, Rongmin. 2012. "Antitumor Effect of a Polypeptide Fraction from Arca subcrenata in Vitro and in Vivo." Mar. Drugs 10, no. 12: 2782-2794.


Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert